Loading...

Nu-Med Plus, Inc.

NUMDPNK
Healthcare
Medical - Devices
$0.01
$-0.00(-8.46%)
U.S. Market opens in 5h 2m

Nu-Med Plus, Inc. (NUMD) Stock Overview

Explore Nu-Med Plus, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap994.2K
P/E Ratio-17.70
EPS (TTM)$0.01
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.02
3 Months$0.05
1 Year Target$0.03

NUMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nu-Med Plus, Inc. (NUMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.70 and a market capitalization of 994.2K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-8.46%
5-Day Change
2.15%
1-Month Change
8.18%
3-Month Change
-47.90%
6-Month Change
-60.33%
Year-to-Date (YTD) Change
-31.13%
1-Year Change
-83.00%
3-Year Change
-8.46%
5-Year Change
-97.34%
All-Time (Max) Change
-98.41%

Contact Information

801 746 3570
455 East 500 South, Salt Lake City, UT, 84111

Company Facts

2 Employees
IPO DateSep 25, 2014
CountryUS
Actively Trading

Frequently Asked Questions